Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory Phase II Study of KRP-203 in Active Crohn's Disease
jRCT2080222062Phase 2
- Sponsor
- Kyorin Pharmaceutical
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Crohn's disease comparing KRP-203 with Placebo (2 arms).
02
Drugs
mocravimod
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on jRCT2080222062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222062.